α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patients

British Journal of Cancer

Volumn 99, Issue 1, 2008, Pages 72-77

  Shah, T ^a   Srirajaskanthan, R ^a   Bhogal, M ^a   Toubanakis, C ^a   Meyer, T ^b   Noonan, A ^a   Witney Smith, C ^a   Amin, T ^a   Bhogal, P ^a   Sivathasan, N ^a   Warner, B ^a   Hochhauser, D ^b   Caplin, M E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

fetoprotein; AFP; ChA; hCG ; Human chorionic gonadotrophin subunit ; Ki 67 MIB 1; Neuroendocrine tumours; Tumour marker

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CHROMOGRANIN A; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 46349094989     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604428     Document Type: Article

References (16)

1. Ardill JE, Erikkson B (2003) The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut. Endocr Relat Cancer 10: 459-462
2. Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P, Chromogranin A (2007) is it a useful marker of neuroendocrine tumors? J Clin Oncol 25: 1967-1973
3. Eriksson B, Oberg K, Skogseid B (1989) Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol 28: 373-377
4. Grossmann M, Trautmann ME, Poertl S, Hoermann R, Berger P, Arnold R, Mann K (1994) Alpha-subunit and human chorionic gonadotropin-beta immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours. Eur J Clin Invest 24: 131-136
5. Heitz PU, von Herbay G, Klöppel G, Komminoth P, Kasper M, Höfler H, Müller KM, Oberholzer M (1987) The expression of subunits of human chorionic gonadotropin (hCG) by nontrophoblastic, nonendocrine, and endocrine tumors. Am J Clin Pathol 88: 467-472
6. Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Oberg K (1997) Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 8: 685-690
7. Lokich JJ, Ganda OP, O'Hara CJ, Warren KW, Moertel CG, Klee G (1987) Alpha-fetoprotein associated with islet cell tumors. Am J Clin Oncol 10: 133-135
8. Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, de Herder WW, Krenning EP, Bouillon R, Lamberts SW (1997) Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 82(8): 2622-2628
9. Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A, UKNETwork for Neuroendocrine Tumours (2005) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 54: iv1-iv16
10. Rindi G, de Herder WW, O'Toole D, Wiedenmann B (2006a) Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: why such guidelines and how we went about it. Neuroendocrinology 84: 155-157
11. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, and all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS) (2006b) TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449: 395-401
12. Solcia E, Kloppel G, Sobin LH (2000) Histologic Typing of Endocrine Tumours. WHO International Histological Classification of Tumours. Heidelberg: Springer Verlag
13. Spear BT (1999) Alpha-fetoprotein gene regulation: lessons from transgenic mice. Cancer Biol 9: 109-116
14. Stenman U-H, Aila T, Alfthan H, Valmu L (2006) The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 12: 769 -784
15. Turner GB, Johnston BT, McCance DR, McGinty A, Watson RG, Patterson CC, Ardill JE (2006) Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut 55: 1586-1591
16. Yuen MF, Lai CL (2005) Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 19: 91-99